Michael Reusch - Concepedia

Author

Michael Reusch

Universität Hamburg

Also Known As

M Reusch, M. K. Reusch, M. Reusch, M.K. Reusch, Michael K. Reusch, Michael Reusch, Reusch, M., Reusch, Michael

127

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Universität Hamburg Astellas Pharma (Netherlands)University Medical Center Hamburg-Eppendorf Dermatologikum Hamburg Showa University

About

Michael Reusch is an author at Universität Hamburg specializing in medicine, dermatology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	416
2	Cell Biology	3	3	68
3	Health Sciences	1	1	103
4	Allergy	1	1	18
5	Cellular Physiology	1	1	12

Michael Reusch

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan Tadao Akizawa, Manabu Iwasaki, Yusuke Yamaguchi, Journal of the American Society of Nephrology	2020	194
The patient benefit index: a novel approach in patient-defined outcomes measurement for skin diseases Matthias Augustin, Marc Alexander Radtke, I. Zschocke, Archives of Dermatological Research Patient Benefit IndexSkin DiseasesOutcomes ResearchPatient-reported OutcomeClinical Dermatology	2009	186
Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, open-label, active-controlled study (DOLOMITES) Jonathan Barratt, Branislav Andrić, Avtandil Tataradze, Nephrology Dialysis Transplantation	2021	136
Prevalence and risk factors of actinic keratoses in Germany – analysis of multisource data Ines Schaefer, Matthias Augustin, C. Spehr, Journal of the European Academy of Dermatology and Venereology	2013	112
Roxadustat for the treatment of anemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, double-blind, placebo-controlled study (ALPS) Evgeny Shutov, Władysław Sułowicz, Ciro Esposito, Nephrology Dialysis Transplantation	2021	112
German psoriasis registry PsoBest: objectives, methodology and baseline data Matthias Augustin, C. Spehr, Marc Alexander Radtke, JDDG Journal der Deutschen Dermatologischen Gesellschaft	2014	106
Intermittent Oral Dosing of Roxadustat in Peritoneal Dialysis Chronic Kidney Disease Patients with Anemia: A Randomized, Phase 3, Multicenter, Open‐Label Study Tadao Akizawa, Tetsuro Otsuka, Michael Reusch, Therapeutic Apheresis and Dialysis ImmunohematologyDialysisRenal PathologyDialysis TherapyPharmacotherapy	2019	103
Roxadustat for the Maintenance Treatment of Anemia in Patients with End-Stage Kidney Disease on Stable Dialysis: A European Phase 3, Randomized, Open-Label, Active-Controlled Study (PYRENEES) Botond Csiky, Michael Schömig, Ciro Esposito, Advances in Therapy	2021	101
The Euromelanoma skin cancer prevention campaign in Europe: characteristics and results of 2009 and 2010 R.J.T. van der Leest, Esther de Vries, Jean‐Luc Bulliard, Journal of the European Academy of Dermatology and Venereology	2011	97
Roxadustat Treatment of Chronic Kidney Disease-Associated Anemia in Japanese Patients Not on Dialysis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial Tadao Akizawa, Manabu Iwasaki, Tetsuro Otsuka, Advances in Therapy	2019	83

Page 1